Brought to you by:
-
The people and devices that put ‘the vascular in vascular’
The people, discoveries, innovations and events that brought the vascular surgery profession to where it is today will form the subject matter for this year’s John Homans Lecture—“Who put the vascular in vascular surgery?”—at VAM 2025. Jerry Goldstone, MD, an adjunct professor at Stanford University College of Medicine, will pore over some of the most…
-
Vascular surgery maintains popularity, becomes ‘more competitive’ after switch to virtual interviews
A study aimed at assessing the impact of a pandemic-related switch to virtual recruitment from in-person interviews on the Match for vascular surgery residents demonstrated that the transition had no impact on the popularity of the specialty. This is among the findings set to be delivered by presenting author Christina Cui, BS, a fourth-year medical…
-
International Chapter highlights pressing need to document PAD and CLTI prevalence in South Asia
There is an urgent need for epidemiological studies to map out the prevalence of chronic limb-threatening ischemia (CLTI)—and peripheral arterial disease (PAD) in general—in South Asia, attendees of the International Chapter Education Session at VAM 2025 heard yesterday morning. That was the message from Prem Chand Gupta, MBBS, clinical director and head of vascular surgery…
-
Learn from other fields to enhance your practice, vascular surgeon innovators told
“A lot of solutions to your problems exist in somebody else’s operating room, or somebody else’s cath lab, but you never actually go there.” These were the words of Alan B. Lumsden, MD, of the Houston Methodist Hospital in Houston, Texas, delivering the keynote talk at yesterday’s Innovation and Entrepreneurship in Vascular Surgery session, during…
-
SVS president will stake ‘reclaiming center’ in VAM 2025 address
One of the singular highlights of VAM 2025—the presidential introduction and address—will take place this morning from 11 a.m.–12 p.m. on Morial CC’s First Floor (Great Hall A), with SVS President Matthew Eagleton, MD, centering his focus on the Society’s anchor in a community commitment to patients and a spirit of shared purpose. The SVS…
-
Transatlantic multicenter experience highlights effectiveness of total endovascular aortic repair with F/BEVAR but 5% risk of major stroke
Staged total endovascular aortic repair (TEAR) utilizing arch branched and thoracoabdominal fenestrated and branched endografts is effective, but identified predictors of morbidity and mortality—including stroke—highlight the importance of individualized risk assessment to optimize outcomes. These are some of the key findings of a study presented during yesterday’s Plenary Session 3. Submitting and presenting author Enrico…
-
Vote for your favorite projects at the Poster Competition
Don’t miss the chance to witness the creativity and hard work of the Poster Competition participants as they compete for top honors, taking place Friday afternoon at VAM 2025 from 12:30–2 p.m. in First Floor, Hall B. This competition offers an opportunity to engage with innovative research, showcasing 10 rows of posters featuring up to…
-
Acellular tissue engineered vessel outperforms AVF in high-risk hemodialysis patients
Results from the CLN-PRO-V007 randomized controlled trial of Humacyte’s acellular tissue engineered vessel (ATEV) are set to be shared today during VAM 2025 Plenary 6 (10–11 a.m., First Floor, Great Hall A), showing several clinical benefits when compared to arteriovenous fistula (AVF) in hemodialysis (HD) patients with a high risk of fistula maturation failure. “ATEV…
-
Greenberg Lecture encourages ‘move beyond’ binary aortic disease classification
Sherene Shalhub, MD, set out a new biologically informed framework that “captures the diverse spectrum of arterial fragility and repair outcomes across inherited and acquired aortic disease” during today’s Roy Greenberg Distinguished Lecture on Innovation at VAM 2025. Shalhub, chief of vascular surgery at Oregon Health and Science University (OHSU) in Portland, Oregon, introduced the…
-
Impact report finds no major change in balance between CAS and CEA following Medicare expansion
An evaluation of trends in the utilization of carotid artery stenting (CAS) versus carotid endarterectomy (CEA) has found there to be “no major change” to tip the balance following the 2023 US Centers for Medicare and Medicaid Services (CMS) expansion of CAS coverage to include standard-risk patients with symptomatic ≥50% and asymptomatic ≥70% carotid artery…